Research Article

Effects of Etanercept on TNF-α Inhibition in Rats with Adenine-Induced Chronic Kidney Disease

Figure 1

Serum TNF-α levels. TNF-α concentration is shown in the different groups. Ad administration significantly increased serum TNF-α levels from the second week, and they remained high until the fourth week of Ad administration compared to the control. Treatment with ETA (Ad+ETA) significantly decreased TNF-α concentrations from week 2 to week 4, compared to the Ad groups without treatment. Values are represented as the , . . Ad: adenine; ETA: etanercept.